Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

Published 2010 View Full Article

Authors

Keywords

Journal

Human vaccines & immunotherapeutics

Volume 5, Issue 10, Pages 705-719

Publisher

Informa UK Limited

Online

2010-01-29

DOI

10.4161/hv.5.10.9518

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Human vaccines & immunotherapeutics

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Create your own webinar